Dermatology · San Diego, CA
NPI
1972990125
Since 2015
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
200 W Arbor Dr, #8425
San Diego, CA, 92103
Phone (619) 543-6268
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,044
53 services
Medicare patients, 2024
15
Average age 60
Drug cost, 2024
$456K
2,370 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Brittany E Yee prescribed most often to Medicare patients was Fluorouracil, with 330 prescriptions and refills. In total Brittany E Yee wrote 2,370 Medicare prescriptions that cost $456K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fluorouracil Generic | 330 | 332 | 259 | $12K |
| Triamcinolone Acetonide Generic | 263 | 311 | 168 | $5,441 |
| Ketoconazole Generic | 244 | 248 | 128 | $3,568 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 203 | 214 | 113 | $4,083 |
| Fluocinonide Generic | 152 | 152 | 75 | $1,996 |
| Clobetasol Propionate Generic | 141 | 147 | 80 | $3,261 |
| Hydrocortisone Generic | 80 | 82 | 61 | $1,120 |
| Doxycycline Monohydrate Generic | 78 | 148 | 67 | $2,715 |
| Vectical Calcitriol | 76 | 82 | 67 | $12K |
| Retin-A Tretinoin | 64 | 74 | 39 | $2,576 |
| Clindamycin Phosphate Generic | 58 | 60 | 35 | $1,333 |
| Metronidazole Generic | 54 | 54 | 38 | $823 |
| Tacrolimus Generic | 53 | 61 | 39 | $4,179 |
| Mupirocin Generic | 49 | 49 | 33 | $493 |
| Pimecrolimus Generic | 47 | 47 | 24 | $5,484 |
Brand drugs: 300 claims; generic drugs: 2,070 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Brittany E Yee were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.